{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-030531","form_type":"8-K","ticker":"COYA","cik":"0001835022","company_name":"Coya Therapeutics, Inc.","filed_at":"2026-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.448377+00:00","generated_at":"2026-05-16T06:04:25.673587+00:00","sec_items":["1.01","3.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Coya Therapeutics raises $11.1M via private placement with Dr. Reddy's and Greenlight Capital","bullets":["Gross proceeds of ~$11.1M from sale of 2,522,727 shares at $4.40 each; no broker/agent.","Dr. Reddy's Labs invests $10M, Greenlight Capital $1.1M; expected close Jan 30, 2026.","Proceeds to accelerate tech transfer and scale-up manufacturing for low dose IL-2 to support COYA 302.","Reiterates cash runway into H2 2027 and past projected ALSTARS trial topline."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-030531","json":"https://secwatch.observer/filing/0001193125-26-030531.json","markdown":"https://secwatch.observer/filing/0001193125-26-030531.md","text":"https://secwatch.observer/filing/0001193125-26-030531.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526030531/0001193125-26-030531-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526030531/d88735d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:04:25.673587+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0578999f21d50af2d0d4a958c754bbfc47e30554","claim":"Coya Therapeutics, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at approximately $11.1 million (effective 2026-01-29).","evidence_excerpt":"On January 29, 2026, Coya Therapeutics, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Securities Purchase Agreement ”) with certain accredited investors","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526030531/0001193125-26-030531-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"approximately $11.1 million"},{"label":"Effective","value":"2026-01-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}